R&D Systems Recombinant Cynomolgus TNF RI/TNFRSF1A Fc Protein CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems 9884TR050
DescriptionThe Recombinant Cynomolgus TNF RI/TNFRSF1A Fc Protein is derived from HEK293. The Recombinant Cynomolgus TNF RI/TNFRSF1A Fc Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in PBS.|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.|
|<0.10 EU per 1μg of the protein by the LAL method.|
|CD120a, CD120a antigen, FPF, p55, p55-R, p60, TNFARMGC19588, TNF-R, TNF-R1, TNFR1TBP1, TNFR55, TNF-R55, TNFR60, TNFRI, TNF-RI, TNF-R-I, TNFR-I, TNFRSF1A, tumor necrosis factor binding protein 1, Tumor necrosis factor receptor 1, tumor necrosis factor receptor 1A isoform beta, tumor necrosis factor receptor superfamily member 1A, tumor necrosis factor receptor superfamily, member 1A, tumor necrosis factor receptor type 1, Tumor necrosis factor receptor type I, tumor necrosis factor-alpha receptor|
|12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution.|
|Reconstitute at 500μg/mL in PBS.|